youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
CTRE:NYSE
Caretrust REIT Inc
$36.14
arrow_downward
-0.70%(-0.26) 1D
$36.40
arrow_upward
+0.72% (+0.26)bedtimeAfter hours
Closed: Nov 2, 4:00:05 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CTRE...
Open
$36.35
High
$36.54
Low
$36.12
Mkt. cap
8.54B
Avg. vol.
2.44M
Volume
5.33M
Dividend
4.16%
Quarterly dividend
$0.38
Ex-dividend date
Sep 30, 2026
P/E ratio
22.78
52-wk high
$43.62
52-wk low
$34.28
EPS
$1.59
Beta
0.73
Shares outstanding
236.29M
No. of employees
43
Open
$36.35
High
$36.54
Low
$36.12
Mkt. cap
8.54B
Avg. vol.
2.44M
Volume
5.33M
Dividend
4.16%
Quarterly dividend
$0.38
Ex-dividend date
Sep 30, 2026
P/E ratio
22.78
52-wk high
$43.62
52-wk low
$34.28
EPS
$1.59
Beta
0.73
Shares outstanding
236.29M
No. of employees
43
News stories
From web sources and news partners
marketscreener.com
·
26 minutes ago
S&P 500 index fell sharply after Stockholm exchange close Monday
BigGo Finance
·
13 minutes ago
Nasdaq Vice Chairman Warns: Taiwan Stocks Climb to World's Fourth Largest, but 79% AI Exposure Tops the Globe
Quantisnow
·
49 minutes ago
Pershing Square USA, Ltd. Releases Third Quarter 2026 Portfolio Review
MarketWatch
·
8 hours ago
Nasdaq Inc. stock outperforms competitors on strong trading day
About Caretrust REIT Inc
CEO-
Employees43
Founded2013
HeadquartersDana Point, California, United States
SectorReal estate investment trust
Websitecaretrustreit.com
Analyst ratings
Based on 11 analysts giving stock ratings to CTRE in the past 3 months
Buy
Buy
8
Hold
3
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for CTRE in the last 3 months.
Highest
Current $36.14
$49.00 (+35.58%)
Average
$44.00 (+21.75%)
Lowest
$41.00 (+13.45%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
John Kilichowski Wells Fargo | Buy | Reiterated | $43.00 | +19% | 10/19/2026 |
Unknown Analyst J.P. Morgan | Hold | Initiated | $41.00 | +13.4% | 10/16/2026 |
Michael Goldsmith UBS | Buy | Reiterated | $44.00 | +21.7% | 10/13/2026 |
Vikram Malhotra Mizuho Securities | Buy | Reiterated | - | - | 10/05/2026 |
Austin Wurschmidt KeyBanc | Buy | Reiterated | $46.00 | +27.3% | 10/06/2026 |
Dave Rodgers Raymond James | Buy | Maintained | $42.00 | +16.2% | 10/05/2026 |
Juan C. Sanabria BMO Capital | Buy | Reiterated | $45.00 | +24.5% | 10/05/2026 |
Michael Carroll RBC Capital | Hold | Maintained | $43.00 | +19% | 10/02/2026 |
Unknown Analyst Huntington Capital Markets | Buy | Initiated | - | - | 09/10/2026 |
Unknown Analyst UBS | Buy | Reiterated | $48.00 | +32.8% | 08/21/2026 |
Farrell Granath Bank of America Securities | Buy | Reiterated | $49.00 | +35.6% | 08/14/2026 |
Richard Anderson Cantor Fitzgerald | Hold | Maintained | $43.00 | +19% | 08/10/2026 |
Unknown Analyst Raymond James | Buy | Initiated | $43.00 | +19% | 06/16/2026 |
Unknown Analyst Deutsche Bank | Buy | Maintained | $43.00 | +19% | 03/23/2026 |
Next call in 3 days
Fri, Nov 6, 11:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.43
Revenue / Est. (USD)
- / 158.95M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 132.44M | 134.86M | 142.78M | 161.35M |
Cost of goods sold | 2.60M | 1.75M | 5.86M | 10.56M |
Cost of revenue | 2.60M | 1.75M | 5.86M | 10.56M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 15.42M | 15.47M | 14.34M | 15.78M |
Operating expense | 42.11M | 42.62M | 43.77M | 46.14M |
Total operating expenses | 44.72M | 44.37M | 49.62M | 56.70M |
Operating income | 87.73M | 90.49M | 93.16M | 104.65M |
Other non operating income | - | 4.35M | - | - |
EBT including unusual items | 77.01M | 114.16M | 81.78M | 90.77M |
EBT excluding unusual items | 74.81M | 83.36M | 81.98M | 89.40M |
Income tax expense | 2.08M | 1.89M | 2.27M | 2.54M |
Effective tax rate | 2.70% | 1.66% | 2.78% | 2.79% |
Other operating expenses | - | - | - | - |
Net income | 74.90M | 111.29M | 80.21M | 89.00M |
Net profit margin | 56.55% | 82.52% | 56.18% | 55.16% |
Earnings per share | 0.33 | 0.36 | 0.36 | 0.39 |
Interest and investment income | - | - | - | - |
Interest expense | -12.62M | -11.38M | -11.24M | -15.32M |
Net interest expenses | -12.62M | -11.38M | -11.24M | -15.32M |
Depreciation and amortization charges | 26.69M | 27.14M | 29.43M | 30.36M |
EBITDA | 109.64M | 117.60M | 122.63M | 135.01M |
Gain or loss from assets sale | - | -27.67M | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events